Arbutus Biopharma Corporation ABUS
Set alert
3.97 USD -0.03 -0.75%
As of Nov 3, 10:47 AM ET
3.98 Day range 4.06
3.50 52-week range 5.45
- YTD
- -17.46%
- 1 year
- -13.32%
- Open
- 4.01
- Prev close
- 4.00
- Mkt cap
- 609.27M
- Vol
- 248.36K
- Avg vol
- 4.92M
- EPS
- 0.79
- P/E
- 5.03
- Div yield
- 0.00%
More statistics
- Low
- 3.98
- High
- 4.06
- Forward P/E
- -30.67
- Beta
- 0.62
- Short ratio
- 5.03
- Inst. own
- 72.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 4.79
- 200-d avg
- 4.52
- 1y target
- 5.46
Analyst view
Consensus: none
Price target (mean) 5.46
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.028 | -0.028 – -0.028 | -0.05601 | +50.0% | 1.39M | +87.4% | 1 |
| Next quarter | -0.028 | -0.028 – -0.028 | -0.01372 | -104.1% | 1.39M | -3.7% | 1 |
| Current year | 1.03 | 1.03 – 1.03 | -0.23321 | +540.4% | 252.84M | +1208.8% | 1 |
| Next year | -0.111 | -0.111 – -0.111 | 1.03 | -110.8% | 5.69M | -97.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Aug 11, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Mar 28, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Jan 21, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 6, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Sep 5, 2024 | Jefferies | Maintained | Buy | Buy |
| Aug 2, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jun 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 5, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 3, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Apr 4, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 1, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Jul 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 6, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 22, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 22, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| May 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 28, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 29, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 20, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 3, 2023 | Chardan Capital | Reiterated | — | Buy |